HPR134 Maintaining Orphan Drug Status at the Time of Drug Approval in European Economic Area (EEA): European Union (EU) Plus Iceland and Norway From 2015 to 2025
Abstract
Authors
Ariane Batscheider Evgeniya Shlaen Darya Schnauffer Adina Akkuliyeva Trang Thanh Vu Stephanie Tanja Zeuch Jana Efremova Christina Meier Doreen Bonduelle Roger-Axel Greiner